Delivery Order SPE2DB22D3501-SPE2DB25FUU65
- Not listed
- This is a $8,281.55 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has an ultimate completion date of July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,895.96, is a Firm Fixed Price Delivery Order for the supply of Losartan-HCTZ 50-12.5 mg tablets. The contract has an ultimate completion date of January 17, 2025 and is not associated with any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $11,544.06, is for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has a completion date of September 24, 2024 and is a Firm Fixed Price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,489.90, is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order with a completion date of March 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,320.65 firm fixed-price delivery order contract is for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of May 16, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This is a $30,269.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The contract has an ultimate completion date of March 26, 2025. This delivery order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,124.82, is for the delivery of 4567666896 Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has a firm fixed price of $30,541.60 and a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This is a $2,494.79 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Losartan-HCTZ 50-12.5 mg tablets. The contract has an ultimate completion date of July 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has a total ceiling value of $23,387.19 and an ultimate completion date of September 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FUU65Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $1,903.12 Firm Fixed Price Delivery Order for the supply of Losartan-HCTZ 50-12.5 mg tablets. The contract has an ultimate completion date of March 6, 2025 and was awarded on March 5, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/5/25 |